Results 71 to 80 of about 515,541 (307)

European Code Against Cancer, 5th edition – hormone replacement therapy, other common medical therapies and cancer

open access: yesMolecular Oncology, EarlyView.
The 5th edition of the European Code Against Cancer (ECAC5) contains 14 recommendations on cancer prevention. Here, we update the cancer prevention recommendations regarding the use of hormone replacement therapy (HRT), which is positioned as recommendation number 13 of the ECAC5.
Mangesh A. Thorat   +18 more
wiley   +1 more source

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

open access: yesMolecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute   +17 more
wiley   +1 more source

Development of a methodological tool for internal control to increase the efficiency of use of fixed assets [PDF]

open access: diamond, 2021
Alsou Zakirova   +4 more
openalex   +1 more source

What Drives Fixed Asset Holding and Risk-Adjusted Performance of Corporate in China? An Empirical Analysis [PDF]

open access: yes
This paper attempts to shed light on the over-investment debate by investigating listed firms in China. Firms with higher level of fixed asset holding, higher level of overhead expenses, and being covered by the tax-favor policy in China are found to be ...
Cai, Dongliang   +2 more
core   +1 more source

ANALISIS FAKTOR-FAKTOR YANG MENDORONG PERUSAHAAN MEREVALUASI ASET TETAP [PDF]

open access: yes, 2017
The inflation volatility in Indonesia demands corporations to choose an accounting policy in order to count the actual rate of the fixed assets. Fixed asset revaluation is a review of a corporate’s fixed asset.
AZIZ, Nidza Annisa   +1 more
core   +1 more source

Monitoring of circulating tumor DNA allows early detection of disease relapse in patients with operable breast cancer

open access: yesMolecular Oncology, EarlyView.
Monitoring circulating tumor DNA (ctDNA) in patients with operable breast cancer can reveal disease relapse earlier than radiology in a subset of patients. The failure to detect ctDNA in some patients with recurrent disease suggests that ctDNA could serve as a supplement to other monitoring approaches.
Kristin Løge Aanestad   +35 more
wiley   +1 more source

Theory and practice of enterprise carbon asset management from the perspective of low-carbon transformation

open access: yesCarbon Management, 2018
Effective carbon asset management is necessary for decreasing carbon resource inputs and reducing carbon emission. Furthermore, carbon asset management is an important measure to realize low-carbon transformation and low-carbon competitiveness for ...
Caiping Zhang   +2 more
doaj   +1 more source

Technological breakthroughs and asset replacement [PDF]

open access: yes
The authors analyze the optimal replacement of assets under continuous and discontinuous technological change. They investigate the variable lifetime of assets in an infinite-horizon replacement problem.
Hritonenko, Natali, Yatsenko, Yuri
core  

Home - About - Disclaimer - Privacy